NO803595L - Fremgangsmaate for fremstilling av 5-amino-(3,4`-bipyridin)-6(1h)-on-1`-oksyd eller farmasoeytiske akseptable syreaddisjonssalter derav - Google Patents

Fremgangsmaate for fremstilling av 5-amino-(3,4`-bipyridin)-6(1h)-on-1`-oksyd eller farmasoeytiske akseptable syreaddisjonssalter derav

Info

Publication number
NO803595L
NO803595L NO803595A NO803595A NO803595L NO 803595 L NO803595 L NO 803595L NO 803595 A NO803595 A NO 803595A NO 803595 A NO803595 A NO 803595A NO 803595 L NO803595 L NO 803595L
Authority
NO
Norway
Prior art keywords
oxid
bipyridine
amino
procedure
preparation
Prior art date
Application number
NO803595A
Other languages
English (en)
Norwegian (no)
Inventor
George Yohe Lesher
Chester Joseph Opalka
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO803595L publication Critical patent/NO803595L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/22Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO803595A 1979-12-03 1980-11-27 Fremgangsmaate for fremstilling av 5-amino-(3,4`-bipyridin)-6(1h)-on-1`-oksyd eller farmasoeytiske akseptable syreaddisjonssalter derav NO803595L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9950379A 1979-12-03 1979-12-03

Publications (1)

Publication Number Publication Date
NO803595L true NO803595L (no) 1981-06-04

Family

ID=22275318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO803595A NO803595L (no) 1979-12-03 1980-11-27 Fremgangsmaate for fremstilling av 5-amino-(3,4`-bipyridin)-6(1h)-on-1`-oksyd eller farmasoeytiske akseptable syreaddisjonssalter derav

Country Status (18)

Country Link
JP (1) JPS56103165A (fr)
KR (1) KR830004247A (fr)
AU (1) AU6472280A (fr)
BE (1) BE886437A (fr)
DE (1) DE3045637A1 (fr)
DK (1) DK513180A (fr)
ES (1) ES8200346A1 (fr)
FI (1) FI803738L (fr)
FR (1) FR2471982A1 (fr)
GB (1) GB2064533A (fr)
IL (1) IL61537A0 (fr)
IT (1) IT8026375A0 (fr)
LU (1) LU82975A1 (fr)
NL (1) NL8006511A (fr)
NO (1) NO803595L (fr)
PT (1) PT72122B (fr)
SE (1) SE8008456L (fr)
ZA (1) ZA807431B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD298781A5 (de) * 1990-03-09 1992-03-12 Inst Wirkstofforschung Verfahren zur herstellung von 5,4'-bipyridin-1'-oxiden
AU2005316540A1 (en) 2004-12-16 2006-06-22 Vertex Pharmaceuticals Incorporated Pyrid-2-ones useful as inhibitors of Tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases

Also Published As

Publication number Publication date
DK513180A (da) 1981-06-04
GB2064533A (en) 1981-06-17
IT8026375A0 (it) 1980-12-02
BE886437A (fr) 1981-06-02
KR830004247A (ko) 1983-07-09
ES497345A0 (es) 1981-10-16
SE8008456L (sv) 1981-06-04
JPS56103165A (en) 1981-08-18
NL8006511A (nl) 1981-07-01
FI803738L (fi) 1981-06-04
LU82975A1 (fr) 1981-07-23
PT72122B (en) 1981-09-29
FR2471982A1 (fr) 1981-06-26
IL61537A0 (en) 1980-12-31
ES8200346A1 (es) 1981-10-16
ZA807431B (en) 1981-11-25
PT72122A (en) 1980-12-01
DE3045637A1 (de) 1981-08-27
AU6472280A (en) 1981-06-11

Similar Documents

Publication Publication Date Title
DK149895C (da) Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf
NO155226C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende benzodiazepiner, dibenzotiepiner eller quinolinmetanolderivater.
NO152935C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.
DK462480A (da) Fremgangsmaade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenaminderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK337383D0 (da) Fremgangsmade til fremstilling af 4-amino-6,7-dimethoxyquinolin-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK464478A (da) Fremgangsmaade til fremstilling af 3-substituerede 6-(1'hydroxyethyl)-m-oxo-1-azabicyclo(3,2,0)hept-2-en-2-carboxylsyrer eller derivater deraf
NO153496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO814424L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 5,5`-azobis-salisylsyreforbindelser.
DK118578A (da) Fr&mgangsmaade til fremstilling af pyridinylaminoalkylethere,n-oxider eller physiologisk acceptable syreadditionssalte deraf
NO821904L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
RO82507A (fr) Procede pour la preparation des derives de l'acide 1,2,3-thiadiazole-procede pour la preparation des derives de l'acide 1,2,3-thiadiazole-5-carboxylique
NO155289C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater.
DK157451C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf
AR223663A1 (es) Procedimiento para la preparacion de derivados 1,6-disustituidos de acido 4-piridon-3-carboxilico
DK134580A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK165790C (da) Fremgangsmaade til fremstilling af adriamycin-4'-o-derivater eller syreadditionssalte deraf
DK430379A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
MX153817A (es) Procedimiento para la preparacion de acido 4,4'-dinitro-estilben-2,2-disulfonico
SE7700533L (sv) Forfarande for framstellning av 3,4-dihydro-2(1h)-kinazolinonderivat
IT7927962A0 (it) Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico.
NO161064C (no) Analogifremgangsmaate til fremstilling av fenyl-nonatetraensyrederivater.
RO80112A (fr) Procede pour preparer l'acide 1,1-dioxopenicilique
NO152558C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive 1-benzyl-1,2,3,6-tetra-hydropyridinderivater
NO803595L (no) Fremgangsmaate for fremstilling av 5-amino-(3,4`-bipyridin)-6(1h)-on-1`-oksyd eller farmasoeytiske akseptable syreaddisjonssalter derav
RO81506A (fr) Procede pour la preparation des derives des acides 1,3,4-thiadiazole-2-carboxyliques